Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
2002 2
2003 1
2004 1
2005 1
2006 1
2007 2
2008 4
2009 10
2010 5
2011 1
2012 3
2013 6
2014 5
2015 7
2016 7
2017 12
2018 17
2019 25
2020 50
2021 62
2022 38
2023 51
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

296 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T; KEYNOTE-426 Investigators. Rini BI, et al. N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16. N Engl J Med. 2019. PMID: 30779529 Clinical Trial.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire.
Nabavi N, Mahdavi SR, Ardalan MA, Chamanara M, Mosaed R, Lara A, Bastos D, Harsini S, Askari E, Velho PI, Bagheri H. Nabavi N, et al. Among authors: bastos d. Biomedicines. 2023 Jul 24;11(7):2084. doi: 10.3390/biomedicines11072084. Biomedicines. 2023. PMID: 37509723 Free PMC article. Review.
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
Zadra G, Ribeiro CF, Chetta P, Ho Y, Cacciatore S, Gao X, Syamala S, Bango C, Photopoulos C, Huang Y, Tyekucheva S, Bastos DC, Tchaicha J, Lawney B, Uo T, D'Anello L, Csibi A, Kalekar R, Larimer B, Ellis L, Butler LM, Morrissey C, McGovern K, Palombella VJ, Kutok JL, Mahmood U, Bosari S, Adams J, Peluso S, Dehm SM, Plymate SR, Loda M. Zadra G, et al. Among authors: bastos dc. Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):631-640. doi: 10.1073/pnas.1808834116. Epub 2018 Dec 21. Proc Natl Acad Sci U S A. 2019. PMID: 30578319 Free PMC article.
Metabolomic analysis of follicular fluid from women with Hashimoto thyroiditis.
Bastos DCDS, Chiamolera MI, Silva RE, Souza MDCB, Antunes RA, Souza MM, Mancebo ACA, Arêas PCF, Reis FM, Lo Turco EG, Bloise FF, Ortiga-Carvalho TM. Bastos DCDS, et al. Sci Rep. 2023 Aug 2;13(1):12497. doi: 10.1038/s41598-023-39514-7. Sci Rep. 2023. PMID: 37532758 Free PMC article.
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.
Fizazi K, Retz M, Petrylak DP, Goh JC, Perez-Gracia J, Lacombe L, Zschäbitz S, Burotto M, Mahammedi H, Gravis G, Bastos DA, McCune SL, Vázquez Limón JC, Kwan EM, Castellano D, Fléchon A, Saad F, Grimm MO, Shaffer DR, Armstrong AJ, Bhagavatheeswaran P, Amin NP, Ünsal-Kaçmaz K, Wang X, Li J, Loehr A, Pachynski RK. Fizazi K, et al. Among authors: bastos da. J Immunother Cancer. 2022 Aug;10(8):e004761. doi: 10.1136/jitc-2022-004761. J Immunother Cancer. 2022. PMID: 35977756 Free PMC article. Clinical Trial.
Pervasive gaps in Amazonian ecological research.
Carvalho RL, Resende AF, Barlow J, França FM, Moura MR, Maciel R, Alves-Martins F, Shutt J, Nunes CA, Elias F, Silveira JM, Stegmann L, Baccaro FB, Juen L, Schietti J, Aragão L, Berenguer E, Castello L, Costa FRC, Guedes ML, Leal CG, Lees AC, Isaac V, Nascimento RO, Phillips OL, Schmidt FA, Ter Steege H, Vaz-de-Mello F, Venticinque EM, Vieira ICG, Zuanon J; Synergize Consortium; Ferreira J. Carvalho RL, et al. Curr Biol. 2023 Aug 21;33(16):3495-3504.e4. doi: 10.1016/j.cub.2023.06.077. Epub 2023 Jul 19. Curr Biol. 2023. PMID: 37473761 Free article.
296 results